Regeneron Pharmaceuticals (REGN) Q4 2025 (USD): Adj. EPS 11.44 (exp. 10.56), Revenue 3.88bln (exp. 3.78bln)
Importance
Level 1
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#REGENERON PHARMACEUTICALS INC#REGN.US#IMPORTANT#FOREX#EQUITIES#METALS#EU SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#REGN#DXY#US EQUITIES